Referred to us by one of their Board members, Iviva needed help clarifying their novel technology to investors and setting the stage for opportunities their technology presents.

While conducting interviews with the executive team and diving into the science, we discovered an element that was missing from their core story. Dr. Ott’s extensive experience in the field of organ engineering and the lessons learned were key to the evolution of Iviva’s technology, and its promising potential to disrupt the current standard-of-care for millions of people on dialysis. With the knowledge gained from our research, we designed a new logo and built a new investor deck and website to demonstrate the value of their transformative science.

Want to learn more? Read our discussion about making the transition from academia to business with Iviva Founder and CEO Harald Ott and Investor and Executive Advisor Brock Reeve here.